MCRB
Seres Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.72
+1.42%Margins
Gross margin
82.6%
EBITDA margin
-2354.9%
EBIT margin
-4462.8%
Net margin
-1192.9%
FCF margin
-2724.1%
-65.0%
Return on equity
-22.1%
Return on assets
-92.2%
Return on invested capital
0.02x
Asset turnover
-$51.3M
Cash from operations
$1.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026